ʻEhā Blu disposable kahea ana nā huahana a me hoʻokahi huahana My Blu vape i hoʻopuka ʻia he Marketing Denial Order (MDO) e ka US Food and Drug Administration iā Fontem US ʻO ka manaʻo o MDO ʻaʻole ʻae ʻia ka hui e kūʻai aku a hoʻolaha i kēia mau huahana blu vape i ʻAmelika Hui Pū ʻIa. Eia nō naʻe, loaʻa iā Fontem US ke koho e hoʻouna i nā noi hou no kēia mau huahana blu vape ʻono.
ʻO nā huahana blu ʻono i hōʻole ʻia me kahi wai menthol e pani ʻia a me nā huahana blu vape ʻono. ʻO nā huahana kikoʻī i loaʻa iā MDO ʻo Blu ʻO ka meaʻai Menthol 2.4 percent; flavored blu disposable Vanilla 2.4 percent; flavored blu disposable Polar Mint 2.4 pakeneka; blu ʻono ʻO ka meaʻai Cherry 2.4 pakeneka; a me MyBlu Menthol 1.2 pakeneka.
No ke aha e hōʻole ai ka FDA i ka Blu Vape?
The FDA reviewed Fontem U.S.’s premarket tobacco product applications and found that they did not provide enough evidence to demonstrate that marketing these flavored blu disposable products would be in the best interest of public health, as required by the 2009 Family Smoking Prevention and Tobacco Control Act. The applications lacked sufficient evidence on harmful ingredients in the aerosol of one product and battery safety for several products. Additionally, the applications did not show enough data to prove that these new products could benefit adult smokers in terms of completely switching from traditional cigarettes or significantly reducing cigarette use. The potential risk to youth also outweighed any potential benefits for adult smokers, according to the FDA.
